3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
70
Squamous Cell Carcinoma of Head and Neck
32
Parkinson Disease 4, Autosomal Dominant Lewy Body
32
Lung Neoplasms
28
Melanoma
25
Triple Negative Breast Neoplasms
23
Neoplasm Metastasis
21
Neoplasms
20
Breast Neoplasms
19
Colorectal Neoplasms
18
Endometrial Neoplasms
16
Head and Neck Neoplasms
15
Ovarian Neoplasms
14
Carcinoma, Renal Cell
13
Urinary Bladder Neoplasms
11
Carcinoma, Transitional Cell
11
Pancreatic Neoplasms
7
Hodgkin Disease
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Stomach Neoplasms
6
Sarcoma
6
Recurrence
6
Lymphoma
6
Carcinoma
6
Brain Neoplasms
6
Small Cell Lung Carcinoma
4
Prostatic Neoplasms
4
Multiple Myeloma
4
Mouth Neoplasms
4
Interventions
selinexor
1
pembrolizumab
1
pazopanib
1
Proton Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Doxorubicin
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
pembrolizumab
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled